Literature DB >> 2784781

Demonstration of two distinct forms of released low affinity-type rat IL-2 receptors.

T Herrmann1, O Josimovic-Alasevic, A Mouzaki, T Diamantstein.   

Abstract

The release of IL-2 binding proteins, derived from the 55,000 MW low affinity IL-2R (L chain), has been observed for virtually all L chain-bearing cells in either humans, the mouse or the rat. Based on the characterization of the released human L chain as a molecule 10,000 MW smaller than the cell surface receptor, either proteolytic cleavage or differential splicing of the L chain encoding mRNA have been suggested as mechanisms underlying the receptor release. Combining affinity labelling of the L chain with [125I]IL-2 and immunoprecipitation with L chain-specific monoclonal antibody (mAb) applied for the detection of soluble rat IL-2R revealed the existence of two classes of soluble receptors, one being of the same size as cell surface-expressed L chain, the other of 40,000 apparent molecular mass. These findings raise the possibility of other mechanisms of receptor release than those discussed for human L chain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784781      PMCID: PMC1385224     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Enzyme-linked immunosorbent assay of mouse interleukin-2 receptors.

Authors:  H Osawa; O Josimovic-Alasevic; T Diamantstein
Journal:  J Immunol Methods       Date:  1986-08-21       Impact factor: 2.303

2.  Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay.

Authors:  H Osawa; O Josimovic-Alasevic; T Diamantstein
Journal:  Eur J Immunol       Date:  1986-04       Impact factor: 5.532

3.  Peptide mapping in one dimension by limited proteolysis of sodium dodecyl sulfate-solubilized proteins.

Authors:  D W Cleveland
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

5.  The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor.

Authors:  T Herrmann; T Diamantstein
Journal:  Immunobiology       Date:  1987-09       Impact factor: 3.144

6.  The released interleukin 2 receptor binds interleukin 2 efficiently.

Authors:  L A Rubin; G Jay; D L Nelson
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

7.  The human intermediate-affinity interleukin 2 receptor consists of two distinct, partially homologous glycoproteins.

Authors:  T Herrmann; T Diamantstein
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

8.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.

Authors:  K Teshigawara; H M Wang; K Kato; K A Smith
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

10.  Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway.

Authors:  M S Krangel
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  1 in total

1.  Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Authors:  E Dagli; J A Warner; C R Besley; J O Warner
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.